Categories AlphaGraphs, Earnings, Retail

Earnings Preview: Best Buy might see robust growth in Q4 on cost savings

Fresh out of the holiday season, Best Buy Co (BBY) looks to post a decent jump in bottom line as it reports fourth-quarter 2019 results on Feb. 27.

The Minnesota-based retail giant has already beaten market estimates in the past four quarters, and if the trend continues, it would be quite a feat in the challenging retail landscape.

For the fourth quarter, the market expects $2.57 in earnings per share on revenue of about $14.7 billion. Both numbers reflect year-over-year growth.

Best Buy has been focusing more on cost savings and bumping up productivity. The retail chain expects to reduce costs by $600 million by fiscal 2021 — it has already reached $465 million.

Catchily named ‘Building the New Blue’ initiative, of which the cost reduction is part of, the move might help Best Buy to regain some solid footing in the market. Expect it to boost the bottom line in the to-be-reported quarter.

Best Buy also recently concluded the buyout of GreatCall — hinting at upcoming health technology offering for senior consumers.

 

LOOKING BACK

In the previously reported third quarter, customer response and favorable market helped lift comp sales by 4.3%, with comp sales across all regions and products rising.

Best Buy third quarter 2019 Earnings Infographic

Due to the robust performance, the retail chain then announced fourth-quarter outlook for enterprise revenues between $14.4 billion and $14.8 billion, with comp sales to be flat to up 3%.

However, despite all this, do expect higher SG&A costs on the retail chain’s push to grow its e-commerce operations and to strengthen its supply chain.

 

 

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top